Cosmo Chemical Balance Sheet Health
Financial Health criteria checks 4/6
Cosmo Chemical has a total shareholder equity of ₩644.5B and total debt of ₩238.6B, which brings its debt-to-equity ratio to 37%. Its total assets and total liabilities are ₩1,091.0B and ₩446.5B respectively. Cosmo Chemical's EBIT is ₩3.0B making its interest coverage ratio 0.4. It has cash and short-term investments of ₩70.3B.
Key information
37.0%
Debt to equity ratio
₩238.60b
Debt
Interest coverage ratio | 0.4x |
Cash | ₩70.29b |
Equity | ₩644.49b |
Total liabilities | ₩446.54b |
Total assets | ₩1.09t |
Recent financial health updates
Is Cosmo Chemical (KRX:005420) Using Too Much Debt?
Apr 17Cosmo Chemical (KRX:005420) Has A Somewhat Strained Balance Sheet
Apr 08Cosmo Chemical (KRX:005420) Has A Somewhat Strained Balance Sheet
Dec 24Recent updates
Is Cosmo Chemical (KRX:005420) Using Too Much Debt?
Apr 17Cosmo Chemical (KRX:005420) Has A Somewhat Strained Balance Sheet
Apr 08Cosmo Chemical (KRX:005420) Has Gifted Shareholders With A Fantastic 209% Total Return On Their Investment
Feb 14Cosmo Chemical (KRX:005420) Has A Somewhat Strained Balance Sheet
Dec 24Financial Position Analysis
Short Term Liabilities: A005420's short term assets (₩377.1B) exceed its short term liabilities (₩323.1B).
Long Term Liabilities: A005420's short term assets (₩377.1B) exceed its long term liabilities (₩123.4B).
Debt to Equity History and Analysis
Debt Level: A005420's net debt to equity ratio (26.1%) is considered satisfactory.
Reducing Debt: A005420's debt to equity ratio has reduced from 126.8% to 37% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if A005420 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if A005420 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.